Chesapeake Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.82M | Sell |
3,703
-1
| -0% | -$543 | 0.56% | 51 |
|
|
2025
Q4 | $2.15M | Sell |
3,704
-100
| -3% | -$56.5K | 0.64% | 47 |
|
|
2025
Q3 | $1.85M | Sell |
3,804
-42
| -1% | -$19.5K | 0.56% | 48 |
|
|
2025
Q2 | $1.56M | Sell |
3,846
-103
| -3% | -$43.1K | 0.52% | 52 |
|
|
2025
Q1 | $1.97M | Sell |
3,949
-137
| -3% | -$74.2K | 0.7% | 46 |
|
|
2024
Q4 | $2.13M | Sell |
4,086
-4
| -0.1% | -$2.2K | 0.73% | 45 |
|
|
2024
Q3 | $2.53M | Sell |
4,090
-96
| -2% | -$56.8K | 0.86% | 40 |
|
|
2024
Q2 | $2.31M | Sell |
4,186
-63
| -1% | -$36.1K | 0.84% | 41 |
|
|
2024
Q1 | $2.47M | Sell |
4,249
-178
| -4% | -$99.9K | 0.9% | 37 |
|
|
2023
Q4 | $2.35M | Sell |
4,427
-71
| -2% | -$34.4K | 0.91% | 34 |
|
|
2023
Q3 | $2.28M | Sell |
4,498
-75
| -2% | -$40K | 0.95% | 32 |
|
|
2023
Q2 | $2.39M | Sell |
4,573
-103
| -2% | -$55.6K | 0.94% | 32 |
|
|
2023
Q1 | $2.7M | Buy |
4,676
+7
| +0.1% | +$3.94K | 1.12% | 24 |
|
|
2022
Q4 | $2.57M | Sell |
4,669
-145
| -3% | -$76.8K | 1.13% | 26 |
|
|
2022
Q3 | $2.44M | Sell |
4,814
-143
| -3% | -$80K | 1.11% | 26 |
|
|
2022
Q2 | $2.69M | Sell |
4,957
-225
| -4% | -$124K | 1.15% | 21 |
|
|
2022
Q1 | $3.06M | Sell |
5,182
-138
| -3% | -$79.3K | 1.11% | 23 |
|
|
2021
Q4 | $3.55M | Sell |
5,320
-148
| -3% | -$92.4K | 1.19% | 21 |
|
|
2021
Q3 | $3.12M | Sell |
5,468
-600
| -10% | -$329K | 1.12% | 21 |
|
|
2021
Q2 | $3.06M | Sell |
6,068
-492
| -8% | -$232K | 0.99% | 22 |
|
|
2021
Q1 | $2.99M | Sell |
6,560
-802
| -11% | -$383K | 1% | 19 |
|
|
2020
Q4 | $3.43M | Sell |
7,362
-120
| -2% | -$56.3K | 1.17% | 18 |
|
|
2020
Q3 | $3.3M | Buy |
7,482
+35
| +0.5% | +$14.5K | 1.23% | 14 |
|
|
2020
Q2 | $2.7M | Buy |
7,447
+116
| +2% | +$38.9K | 1.07% | 19 |
|
|
2020
Q1 | $2.08M | Buy |
7,331
+93
| +1% | +$29.3K | 0.96% | 21 |
|
|
2019
Q4 | $2.35M | Buy |
7,238
+295
| +4% | +$89.5K | 0.91% | 22 |
|
|
2019
Q3 | $2.02M | Buy |
6,943
+260
| +4% | +$74.5K | 0.82% | 26 |
|
|
2019
Q2 | $1.96M | Buy |
6,683
+1,013
| +18% | +$279K | 0.82% | 26 |
|
|
2019
Q1 | $1.55M | Buy |
5,670
+442
| +8% | +$110K | 0.68% | 37 |
|
|
2018
Q4 | $1.17M | Buy |
5,228
+626
| +14% | +$147K | 0.58% | 46 |
|
|
2018
Q3 | $1.12M | Buy |
4,602
+209
| +5% | +$48.1K | 0.5% | 53 |
|
|
2018
Q2 | $910K | Buy |
4,393
+249
| +6% | +$52.9K | 0.42% | 64 |
|
|
2018
Q1 | $856K | Buy |
+4,144
| New | +$870K | 0.4% | 71 |
|
Other funds holding TMO
VCM
Chesapeake Wealth Management's TMO Position: Q1 2026 in Review
Chesapeake Wealth Management reduced its Thermo Fisher Scientific (TMO) stake by 0.03% in Q1 2026, selling an estimated $543 and leaving 3,703 shares worth $1.82M. The position accounts for 0.56% of the portfolio, ranked #51.
Chesapeake Wealth Management first reported a position in TMO in Q1 2018 and has held it in 33 quarters since. The position peaked at $3.55M in Q4 2021. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- Chesapeake Wealth Management held 3,703 shares of Thermo Fisher Scientific worth $1.82M as of Q1 2026.
- Chesapeake Wealth Management sold 1 Thermo Fisher Scientific share in Q1 2026, an estimated $543.
- Thermo Fisher Scientific made up 0.56% of Chesapeake Wealth Management's portfolio in Q1 2026, its #51 holding.
- Chesapeake Wealth Management first reported a position in Thermo Fisher Scientific in Q1 2018 and has held it in 33 quarters since.
- Chesapeake Wealth Management's Thermo Fisher Scientific position peaked at $3.55M in Q4 2021.
- 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on Chesapeake Wealth Management's 13F filing for Q1 2026, filed 18 May 2026.